Business
Johnson & Johnson COVID-19 vaccine under review by European Medicines Agency over blood clots – ABC News
Europe’s drug regulator says it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson’s COVID-19 vaccine.
Europes drug regulator says it is reviewing rare blood clots in four people in the United States who received Johnson & Johnsons COVID-19 vaccine.
Key points:
- Johnson & Johnson said it was aware of the rare reports of blood clots, and was working with regulators to assess the data
- The US Food and Drug Administration said it was aware of the reports, but they had “not found a causal relationship with vaccination”
- It follows an investigation of blood clots reported by some people given the AstraZeneca…
Continue Reading
-
General22 hours agoDriver charged after fatal alleged hit-run crash at Hillier
-
General23 hours ago‘Fortune teller’ allegedly defrauds Sydney’s Vietnamese community out of $70 million
-
Business22 hours agoOctober 2025 update boosts sales and storage
-
General11 hours agoLabor backbencher Dave Kelly hopes WA government’s Dion Barber compensation appeal fails